Sporadic CRC molecular carcinogenesis is a well-known process to date; a new classification was summarized in 2010 and included three different molecular pathways: a traditional pathway (driven by early APC point mutations), an alternative pathway (involving KRAS or APC mutations), and a serrate pathway (showing early BRAF mutations) [99]. The gene discussed is APC; the disease is colorectal carcinoma.